Helius Medical Technologies, Inc. (HSDT)
- Previous Close
0.6760 - Open
0.6850 - Bid 0.6490 x 100
- Ask 0.7002 x 100
- Day's Range
0.6740 - 0.7024 - 52 Week Range
0.6500 - 9.8900 - Volume
92,064 - Avg. Volume
226,965 - Market Cap (intraday)
2.411M - Beta (5Y Monthly) 1.62
- PE Ratio (TTM)
-- - EPS (TTM)
-9.7000 - Earnings Date Nov 7, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.00
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
heliusmedical.comRecent News: HSDT
View MorePerformance Overview: HSDT
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSDT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSDT
View MoreValuation Measures
Market Cap
2.41M
Enterprise Value
-3.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.32
Price/Book (mrq)
0.38
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-76.06%
Return on Equity (ttm)
-161.97%
Revenue (ttm)
594k
Net Income Avi to Common (ttm)
-8.84M
Diluted EPS (ttm)
-9.7000
Balance Sheet and Cash Flow
Total Cash (mrq)
6.39M
Total Debt/Equity (mrq)
0.55%
Levered Free Cash Flow (ttm)
-5.85M